Foundayo Safety Guide

Foundayo side effects: what the data actually shows

By Iacob Pastina · Independent Researcher · Updated May 2026

The most common Foundayo side effects are gastrointestinal: nausea (35%), diarrhea (25%), vomiting (24%), and constipation (24%). 98% of GI side effects in the ATTAIN-1 trial were mild to moderate and improved over time. Foundayo (orforglipron) is Eli Lilly's first oral GLP-1 receptor agonist, FDA-approved April 1, 2026. Unlike Rybelsus (oral semaglutide), Foundayo has no fasting requirement and no food restrictions. All percentages below come from the FDA-approved Foundayo prescribing information.

Call your doctor or 911 immediately if you experience:

• Severe upper abdominal pain radiating to the back (possible pancreatitis — call 911)
• Difficulty breathing, throat swelling, or widespread hives (call 911)
• Inability to keep fluids down for 24+ hours (kidney-injury risk — call your provider or ER)
• Sharp upper-right pain after fatty meals with fever or jaundice (gallbladder — provider call)
• New or worsening suicidal thoughts (call your provider AND 988)

Report any serious adverse event to FDA MedWatch.

Common side effects: rates from the Foundayo label

Source: FDA-approved prescribing information for Foundayo (orforglipron 3mg–36mg), based on the ATTAIN-1 and OASIS-4 trials.

Side effect	Rate	Severity	When it peaks
Nausea	35%	Mild to moderate	Weeks 4-12 (during dose escalation)
Diarrhea	25%	Mild to moderate	Weeks 1-8
Vomiting	24%	Mild to moderate	Weeks 4-12
Constipation	24%	Mild	Weeks 4-16
Abdominal pain	~14%	Mild cramping (severe pain is a red flag)	Weeks 1-8
Headache	~10%	Mild	Weeks 1-4
Decreased appetite	Common	Often perceived as benefit	Weeks 2-12
Fatigue	~8%	Mild	Weeks 1-8
Hair loss (telogen effluvium)	5.4%	Cosmetic — temporary	Months 3-6 (related to rapid weight loss, not the drug directly)

What's different about Foundayo vs other GLP-1s

• Oral pill, not injection. No needles, no pen device, no refrigeration.
• No fasting requirement. Take it any time, with or without food. Unlike Rybelsus (oral semaglutide), which requires 30 min fasted with only 4oz of water.
• Once-daily dosing. Daily pill instead of weekly injection. Some users prefer the routine; some find it harder to remember.
• Lower weight loss than injectables. 12.4% in trials vs Wegovy's 14.9% and Zepbound's 20.9%. Tradeoff for the convenience of an oral pill.
• Self-pay starting at $149/mo — the lowest cash price for any FDA-approved brand-name GLP-1 weight-loss medication in the US market.

What to expect, week by week

Foundayo uses a 4-week-step titration: 3mg starter → 6mg → 12mg → optional 24mg or 36mg.

Weeks 1-4 (3mg starter)

What's typical: Mild nausea (10-15% of patients), occasional headache, possible early appetite reduction. The starter dose is intentionally sub-therapeutic to let the gut adjust.

Red flags: Persistent vomiting, severe abdominal pain, allergic reaction symptoms.

Weeks 5-8 (6mg therapeutic minimum)

What's typical: Nausea peaks for many users (around 30-35%). Appetite suppression more pronounced. ATTAIN-1 showed measurable weight loss begins here.

Red flags: Inability to keep fluids down for 24+ hours, severe upper abdominal pain radiating to back, fever.

Weeks 9-12 (12mg)

What's typical: GI symptoms commonly peak then begin diminishing. Constipation more common as caloric intake drops. By week 12 most users have lost 4-7% of baseline body weight.

Red flags: Worsening symptoms instead of improving — discuss dose-hold with your provider before considering the 24mg or 36mg doses.

Weeks 13-16 (12mg or escalate)

What's typical: Maintenance dose for many users at 12mg. Further escalation to 24mg or 36mg only if weight-loss progress plateaus and tolerance is good. Hair shedding may begin around month 3-4 in some users.

Red flags: New or worsening upper-right abdominal pain (gallbladder), severe fatigue with low urine output (kidney).

Weeks 17+ (12-36mg maintenance)

What's typical: Stable dose. ATTAIN-1 reported 12.4% average weight loss at 36mg over 72 weeks. GI symptoms minimal for most users by this point.

Red flags: Any new symptom that emerges months into treatment warrants a provider call — late-onset pancreatitis and gallbladder issues do occur.

Management protocols for the most common side effects

Nausea (35% of patients)

• Eat smaller, more frequent meals (5-6 small instead of 3 large)
• Avoid fatty, fried, spicy, or highly aromatic foods during dose escalation
• Stay hydrated with small sips throughout the day; ginger or peppermint tea helps many users
• Take Foundayo at the same time each day; if nausea is worst in the morning, try evening dosing
• Most providers will hold dose escalation for 4 additional weeks if nausea is intolerable rather than push to 24mg

Diarrhea (25%) and Vomiting (24%)

• Maintain hydration as the priority — water plus electrolytes (sports drinks, oral rehydration salts)
• BRAT diet (bananas, rice, applesauce, toast) for diarrhea
• Avoid caffeine, alcohol, and dairy during acute symptoms
• If you cannot keep fluids down for 24 hours, call your provider — risk of dehydration-induced kidney injury

Constipation (24%)

• Increase fiber gradually (25-30g/day) — too much too fast worsens GI symptoms
• Drink at least 64oz of water daily, more if active
• Walking 30 minutes daily helps gut motility
• OTC stool softeners (docusate) are safe for short-term use; check with provider before laxatives
• Persistent constipation past 1 week with abdominal distension warrants a provider call

Hair shedding (5.4%)

• This is telogen effluvium — caused by rapid weight loss, not the drug acting on hair follicles directly
• Ensure 60-80g/day of protein intake (this is harder than it sounds when appetite is suppressed)
• Test ferritin (iron storage), vitamin D, and biotin BEFORE supplementing — random supplementation can mask deficiencies
• Regrowth typically begins 3-6 months after weight stabilizes

Serious side effects — recognize these red flags

Rare but serious. Knowing the warning signs is the difference between a manageable problem and an emergency.

Pancreatitis

<0.5% (rare but serious)

Red-flag symptoms: Severe upper abdominal pain radiating to the back, with persistent nausea or vomiting

Action: STOP Foundayo and seek emergency care immediately. Do not restart without provider clearance.

Gallbladder problems

Reported in trials at rates similar to other GLP-1s (1-3%)

Red-flag symptoms: Sharp upper-right abdominal pain after fatty meals, fever, jaundice

Action: Contact your provider for imaging. Rapid weight loss is the primary risk factor.

Acute kidney injury

Rare

Red-flag symptoms: Decreased urine output, swelling, fatigue — usually after persistent vomiting or diarrhea causing dehydration

Action: Maintain aggressive hydration during GI symptoms. If you cannot keep fluids down for 24 hours, contact your provider or ER.

Hypoglycemia

Variable — primarily in patients also taking insulin or sulfonylureas

Red-flag symptoms: Shakiness, sweating, confusion, rapid heartbeat, blurred vision

Action: Treat immediately with 15g fast-acting carbs (juice, glucose tablets). Recheck in 15 minutes. Discuss insulin/sulfonylurea dose reduction with your prescriber if recurring.

Severe allergic reaction (anaphylaxis)

Rare (<0.1%)

Red-flag symptoms: Difficulty breathing, throat or facial swelling, widespread hives, drop in blood pressure

Action: CALL 911. Do not drive yourself.

Suicidal ideation

Under FDA post-marketing review (class-wide, no causal link established)

Red-flag symptoms: New or worsening depression, mood changes, self-harm thoughts

Action: Contact your provider AND report to FDA MedWatch (1-800-FDA-1088). The 988 Suicide & Crisis Lifeline is available 24/7.

The boxed warning: thyroid C-cell tumors

Foundayo carries a boxed warning for thyroid C-cell tumors as a class-wide labeling for GLP-1 receptor agonists. However, one Foundayo-specific data point: orforglipron did not produce thyroid tumors in the rodent studies that led to the boxed warning for injectable GLP-1s like Wegovy and Ozempic. The FDA retained the class-level warning out of regulatory caution, not because of orforglipron-specific findings.

Foundayo is contraindicated in patients with:

• Personal or family history of medullary thyroid carcinoma (MTC)
• Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

Your prescriber should screen for these before initiating Foundayo. If a telehealth provider does not ask about thyroid history during intake, treat that as a quality flag — programs with stronger clinical oversight catch this systematically.

Choosing a provider for Foundayo

Foundayo became commercially available April 6, 2026. As of mid-2026, five telehealth partners verified by GLP-1 Picks offer it: Ro ($149-$299/mo), Sesame Care ($149/mo), Shed ($149/mo), Lemonaid Health, and Found. Eli Lilly's direct-to-consumer LillyDirect also offers it. The medical-oversight pattern still matters: programs that include regular check-ins, willingness to hold dose escalation, and labs to catch issues early earn their place during the 16-week titration window.

Among the 48 GLP-1 telehealth providers we track, Eden Health (8.9/10) is our highest-rated for medical oversight: board-certified obesity medicine physicians, quarterly blood panels included, and a published protocol for dose-hold during intolerable side effects.

See how all 48 providers score on clinical oversight in the full rankings, or take the 60-second match quiz to find providers that fit your support needs.

Wegovy side effects deep dive — for users comparing oral Foundayo to injectable semaglutide
Zepbound side effects deep dive — tirzepatide for weight loss (higher loss but injectable)
Ozempic side effects deep dive
Foundayo vs Wegovy pill: $149 vs $1,349/mo head-to-head
Foundayo (orforglipron) guide 2026 — full overview of the new oral GLP-1
Cross-drug GLP-1 side effects comparison

Sources

This page is for informational purposes only and is not medical advice. Always discuss medication decisions with a licensed prescriber. Side-effect rates are population averages from clinical trials and may not reflect your individual experience. If you are experiencing a medical emergency, call 911.